LLY

732.88

+0.07%↑

JNJ

177.5

+0.27%↑

ABBV

211.68

+0.66%↑

UNH

308.79

-0.21%↓

AZN

80.16

+0.34%↑

LLY

732.88

+0.07%↑

JNJ

177.5

+0.27%↑

ABBV

211.68

+0.66%↑

UNH

308.79

-0.21%↓

AZN

80.16

+0.34%↑

LLY

732.88

+0.07%↑

JNJ

177.5

+0.27%↑

ABBV

211.68

+0.66%↑

UNH

308.79

-0.21%↓

AZN

80.16

+0.34%↑

LLY

732.88

+0.07%↑

JNJ

177.5

+0.27%↑

ABBV

211.68

+0.66%↑

UNH

308.79

-0.21%↓

AZN

80.16

+0.34%↑

LLY

732.88

+0.07%↑

JNJ

177.5

+0.27%↑

ABBV

211.68

+0.66%↑

UNH

308.79

-0.21%↓

AZN

80.16

+0.34%↑

Search

Co-Diagnostics Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

0.27 -15.62

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

0.27

Max

0.32

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-197K

-7.7M

Pardavimai

113K

163K

Pelno marža

-4,745.023

Darbuotojai

132

EBITDA

-526K

-7.8M

Dividendai

By Dow Jones

Kitas uždarbis

2025-11-06

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

4.2M

13M

Ankstesnė atidarymo kaina

15.89

Ankstesnė uždarymo kaina

0.27

Naujienos nuotaikos

By Acuity

39%

61%

130 / 371 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Bearish Evidence

Co-Diagnostics Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-09-02 23:07; UTC

Įsigijimai, susijungimai, perėmimai

Broadwood Partners Plans to Vote Against Staar Sale to Alcon

2025-09-02 22:10; UTC

Pagrindinės rinkos jėgos

Bruker Shares Fall on Convertible Share Offering Aimed at Debt Repayment

2025-09-02 21:47; UTC

Uždarbis

Alimentation Couche-Tard Logs Lower Profit, Revenue in 1Q

2025-09-02 16:52; UTC

Pagrindinės rinkos jėgos

CleanCore Solutions Shares Drop After $175 Million Private Investment

2025-09-02 22:47; UTC

Rinkos pokalbiai

Google, Apple Can Grow AI Deal With Lawsuit Resolved -- Market Talk

2025-09-02 21:40; UTC

Įsigijimai, susijungimai, perėmimai

Investors Have to Be Ready for State Capitalism. What Areas to Watch. -- Barrons.com

2025-09-02 21:07; UTC

Uždarbis

Couche-Tard 1Q U.S. Same-Store Merchandise Revenue Up 0.4% >ATD.T

2025-09-02 21:07; UTC

Uždarbis

Couche-Tard 1Q Canada Same-Store Merchandise Revenue Up 4.1% >ATD.T

2025-09-02 21:05; UTC

Uždarbis

Couche-Tard 1Q Rev $17.35B >ATD.T

2025-09-02 21:05; UTC

Uždarbis

Couche-Tard 1Q Adj EPS 78c >ATD.T

2025-09-02 21:05; UTC

Uždarbis

Couche-Tard 1Q EPS 82c >ATD.T

2025-09-02 21:05; UTC

Uždarbis

Couche-Tard 1Q Net $782.5M >ATD.T

2025-09-02 21:00; UTC

Rinkos pokalbiai

ESG Roundup: Market Talk

2025-09-02 20:53; UTC

Rinkos pokalbiai
Įsigijimai, susijungimai, perėmimai

Knight-Swift Transportation Endorses Union Pacific, Norfolk Southern Merger -- Market Talk

2025-09-02 20:51; UTC

Įsigijimai, susijungimai, perėmimai

Buffett Dislikes Breakup of Kraft Heinz. It's Been One of His Worst Investments. -- Barrons.com

2025-09-02 20:50; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2025-09-02 20:27; UTC

Uždarbis

NIO Stock Rises After Second-Quarter Loss Narrows -- Barrons.com

2025-09-02 20:24; UTC

Įsigijimai, susijungimai, perėmimai

Air Lease Is Going Private. Why Boeing Stock Is Up. -- Barrons.com

2025-09-02 20:18; UTC

Įsigijimai, susijungimai, perėmimai

Procter & Gamble Does Not Endorse Tutanota's Unsolicited Mini-Tender Offer >PG

2025-09-02 20:17; UTC

Įsigijimai, susijungimai, perėmimai

Procter & Gamble: Tutanota Says It Expects to Extend Offer for Successive Periods of Up to 180 Days Until Market Price Exceeds Offer Price >PG

2025-09-02 20:16; UTC

Įsigijimai, susijungimai, perėmimai

Procter & Gamble: 'Shareholders Who Tender Their Shrs in the Offer Will Receive a Below-Market Price' >PG

2025-09-02 20:16; UTC

Įsigijimai, susijungimai, perėmimai

Procter & Gamble: Offer by Tutanota Is to Purchase Up to 500,000 Shrs at $128 Each

2025-09-02 20:15; UTC

Įsigijimai, susijungimai, perėmimai

Procter & Gamble Has Been Notified of Unsolicited Mini-Tender Offer by Tutanota >PG

2025-09-02 19:55; UTC

Uždarbis

GM Had a Record Month of EV Sales. A 'Collapse' Is Coming. -- Barrons.com

2025-09-02 19:50; UTC

Įsigijimai, susijungimai, perėmimai

Food Giants Are Struggling. Could Mergers, Spinoffs, and Activist Stakes Help? -- Barrons.com

2025-09-02 19:09; UTC

Rinkos pokalbiai

Oil Futures Gain on Geopolitical Premium -- Market Talk

2025-09-02 19:00; UTC

Rinkos pokalbiai

U.S. Natural Gas Futures Recover $3 Level -- Market Talk

2025-09-02 18:12; UTC

Rinkos pokalbiai

Gold Pushes To New Record -- Market Talk

2025-09-02 17:04; UTC

Rinkos pokalbiai

Philip Morris Riding Smoke-Free Products to Higher Margins -- Market Talk

2025-09-02 16:57; UTC

Įsigijimai, susijungimai, perėmimai

Air Lease Is Going Private. Why Boeing Stock Is Up. -- Barrons.com

Akcijų palyginimas

Kainos pokytis

Co-Diagnostics Inc Prognozė

Bendras įvertinimas

By TipRanks

Neutralu

1 ratings

0

Pirkti

1

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

0.3495 / 0.3699Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Bearish Evidence

Vidutinės trukmės periodas

Weak Bearish Evidence

Ilgalaikis periodas

No Evidence

Rinkos nuotaikos

By Acuity

130 / 371 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Bulių rinkos įrodymas

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Co-Diagnostics Inc

Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction (PCR) testing to patients in point-of-care and at-home setting. It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah.